Canada Research Roundup: Ascot Resources, Eupraxia Pharmaceuticals, Sprott

Capital Power

26/06/2025 14:40

June 26 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies including Ascot Resources, Eupraxia Pharmaceuticals and Sprott on Thursday.

HIGHLIGHTS

* Ascot Resources Ltd AOT.TO: BMO cuts to market perform from outperform
* Eupraxia Pharmaceuticals Inc EPRX.TO: H.C. Wainwright initiates coverage with buy rating
* Sprott Inc SII.TO: BMO raises target price to C$94 from C$80

Following is a summary of research actions on Canadian companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* Ascot Resources Ltd AOT.TO: BMO cuts to market perform from outperform
* Canadian Natural Resources Ltd CNQ.TO: Wells Fargo raises PT C$46 from C$42
* Eupraxia Pharmaceuticals Inc EPRX.TO:H.C. Wainwright initiates coverage with buy rating
* Sprott Inc SII.TO: BMO raises target price to C$94 from C$80
* Suncor Energy Inc SU.TO: Wells Fargo raises target price to C$60 from C$59

 (Compiled by Bengaluru Newsroom)

 ((Diaries@thomsonreuters.com))